Back to RU Rubric Capital Management LP
TEVA
Showing 8 of 15 quarters
Position history for RURubric Capital Management LP's holdings in Teva Pharmaceutical Industries Limited
As of its Q2 2026 13F, Rubric Capital Management held 15,575,000 shares of TEVA (Teva Pharmaceutical Industries), worth $527.7M. Rubric Capital Management's 13F filings listed TEVA from Q1 2023 to Q2 2026, 14 quarterly filings. TEVA was 4.8% of Rubric Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$374.7M
Total Shares Change
-17M
Quarter-by-Quarter History